Morgan Stanley Sc Pharmaceuticals Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,147,886 shares of SCPH stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,147,886

Previous 1,886,141 13.88%

Holding current value

$12.2 Million

Previous $4.96 Million 64.98%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$2.02 - $4.27 $528,724 - $1.12 Million	261,745 Added 13.88%	2,147,886 $8.18 Million
Q1 2025 May 15, 2025	SELL	$2.63 - $3.68 $62,980 - $88,124	-23,947 Reduced 1.25%	1,886,141 $4.96 Million
Q4 2024 Feb 14, 2025	BUY	$3.14 - $4.53 $4.95 Million - $7.15 Million	1,577,434 Added 474.2%	1,910,088 $6.76 Million
Q3 2024 May 14, 2025	BUY	$4.12 - $5.51 $458,815 - $613,610	111,363 Added 50.32%	332,654 $1.52 Million
Q3 2024 Nov 14, 2024	BUY	$4.12 - $5.51 $458,815 - $613,610	111,363 Added 50.32%	332,654 $1.52 Million
Q2 2024 May 14, 2025	SELL	$3.51 - $5.21 $5.93 Million - $8.8 Million	-1,688,797 Reduced 88.41%	221,291 $962,000
Q2 2024 Oct 17, 2024	BUY	$3.51 - $5.21 $142,404 - $211,374	40,571 Added 22.45%	221,291 $962,000
Q2 2024 Aug 14, 2024	BUY	$3.51 - $5.21 $142,404 - $211,374	40,571 Added 22.45%	221,291 $962,000
Q1 2024 Oct 17, 2024	SELL	$4.86 - $6.39 $197,175 - $259,248	-40,571 Reduced 18.33%	180,720 $907,000
Q1 2024 Aug 16, 2024	SELL	$4.86 - $6.39 $86,828 - $114,163	-17,866 Reduced 9.0%	180,720 $907,000
Q1 2024 May 15, 2024	SELL	$4.86 - $6.39 $86,828 - $114,163	-17,866 Reduced 9.0%	180,720 $907,000
Q4 2023 Aug 16, 2024	SELL	$4.7 - $6.63 $106,713 - $150,534	-22,705 Reduced 10.26%	198,586 $1.25 Million
Q4 2023 Feb 13, 2024	SELL	$4.7 - $6.63 $4.4 Million - $6.21 Million	-936,993 Reduced 82.51%	198,586 $1.25 Million
Q3 2023 Nov 15, 2023	SELL	$7.0 - $9.82 $180,502 - $253,218	-25,786 Reduced 2.22%	1,135,579 $8.09 Million
Q2 2023 Aug 14, 2023	SELL	$8.94 - $11.74 $55,392 - $72,741	-6,196 Reduced 0.53%	1,161,365 $11.8 Million
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $5.69 Million - $9.65 Million	1,018,583 Added 683.71%	1,167,561 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $223,869 - $419,338	55,689 Added 59.7%	148,978 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $10,814 - $15,739	-2,414 Reduced 2.52%	93,289 $608,000
Q2 2022 Oct 27, 2022	BUY	$4.3 - $6.48 $39,207 - $59,084	9,118 Added 10.53%	95,703 $461,000
Q2 2022 Aug 15, 2022	BUY	$4.3 - $6.48 $39,207 - $59,084	9,118 Added 10.53%	95,703 $461,000
Q1 2022 Oct 27, 2022	SELL	$3.9 - $6.11 $35,560 - $55,710	-9,118 Reduced 9.53%	86,585 $492,000
Q1 2022 May 13, 2022	BUY	$3.9 - $6.11 $45,825 - $71,792	11,750 Added 15.7%	86,585 $492,000
Q4 2021 Feb 14, 2022	BUY	$3.88 - $6.9 $18,398 - $32,719	4,742 Added 6.77%	74,835 $375,000
Q3 2021 Nov 15, 2021	BUY	$4.93 - $7.15 $345,558 - $501,164	70,093 New	70,093 $465,000

Others Institutions Holding SCPH

# of Institutions

101

Shares Held

37.8M

Call Options Held

757K

Put Options Held

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $155M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account